Search

Date 2017 Author/Creator Bastholt, L.

1. EURO-VOYAGE: Effectiveness and safety of ipilimumab (IPI) administered during a European Expanded Access Programme (EAP) in patients with advanced melanoma (MEL). (February 2017)

Authors:
Ascierto, P.; Bastholt, L.; Mohr, P.; Hoeller, C.; Robert, C.; Larkin, J.; Dummer, R.; Ekbom, A.; Chiarion-Sileni, V.; Dutriaux, C.; Mortier, L.; Neyns, B.; Nyakas, M.; Garbe, C.; Baurain, J.F.; Kruse, V.; Svane, I.M.; Alfaya, L.; Ciria, C.; Blank, C.
Journal:
European journal of cancer
Issue:
Volume 72(2017)Supplement 1
Page Start:
S128
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments. (April 2017)

Authors:
Kandolf Sekulovic, L.; Peris, K.; Hauschild, A.; Stratigos, A.; Grob, J.-J.; Nathan, P.; Dummer, R.; Forsea, A.-M.; Hoeller, C.; Gogas, H.; Demidov, L.; Lebbe, C.; Blank, C.; Olah, J.; Bastholt, L.; Herceg, D.; Neyns, B.; Vieira, R.; Hansson, J.; Rutkowski, P.
Journal:
European journal of cancer
Issue:
Volume 75(2017)
Page Start:
313
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. PD‐L1 expression and survival among melanoma patients treated with standard immunotherapy or chemotherapy. (31st January 2017)

Authors:
Steiniche, T.; Vestergaard Danielsen, A.; Wang, Z.; Feng, Y.; Switten Nielsen, P.; Bastholt, L.; Schmidt, H.; Svane, I.M.; Dolled‐Filhart, M.; Emancipator, K.; Weiner, R.; Busch‐Sørensen, M.; Zhou, W.
Journal:
Journal of the European Academy of Dermatology and Venereology
Issue:
Volume 31:Number 7(2017)
Page Start:
e319
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗